Brainsway (BWAY)
(Delayed Data from NSDQ)
$10.32 USD
+0.09 (0.88%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $10.28 -0.04 (-0.39%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$10.32 USD
+0.09 (0.88%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $10.28 -0.04 (-0.39%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth F Momentum B VGM
Zacks News
Is Brainsway (BWAY) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Brainsway Ltd. Sponsored ADR (BWAY) and Intuitive Surgical, Inc. (ISRG) have performed compared to their sector so far this year.
Strong Segmental Performance to Drive Stryker's Q3 Earnings
by Zacks Equity Research
SYK's third-quarter 2024 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued to hurt margins.
Wall Street Analysts Believe Brainsway (BWAY) Could Rally 32.01%: Here's is How to Trade
by Zacks Equity Research
The consensus price target hints at a 32% upside potential for Brainsway (BWAY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here's Why Momentum in Brainsway (BWAY) Should Keep going
by Zacks Equity Research
Brainsway (BWAY) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Are Medical Stocks Lagging Brainsway (BWAY) This Year?
by Zacks Equity Research
Here is how Brainsway Ltd. Sponsored ADR (BWAY) and Intuitive Surgical, Inc. (ISRG) have performed compared to their sector so far this year.
Does Brainsway (BWAY) Have the Potential to Rally 34.38% as Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at a 34.4% upside potential for Brainsway (BWAY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
Brainsway (BWAY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Brainsway (BWAY) Soars 14.5%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Brainsway (BWAY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks.com featured highlights include Byrna Technologies, Idaho Strategic Resources, Limbach Holdings, Sezzle and BrainsWay
by Zacks Equity Research
Byrna Technologies, Idaho Strategic Resources, Limbach Holdings, Sezzle and BrainsWay have been highlighted in this Screen of The Week article.
Recent Price Trend in Brainsway (BWAY) is Your Friend, Here's Why
by Zacks Equity Research
Brainsway (BWAY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
5 Stocks With Recent Price Strength to Enhance Your Portfolio
by Nalak Das
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are BYRN, IDR, LMB, SEZL, BWAY.
4 Stocks Worth Adding to Your Portfolio on Solid Net Profit Margin
by Anirudha Bhagat
Let's take a look at four top-ranked stocks - BWAY, QFIN, GLDD and GRC - with impressive net profit margins for a robust portfolio.
Is Butterfly Network (BFLY) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Butterfly Network, Inc. (BFLY) and Brainsway Ltd. Sponsored ADR (BWAY) have performed compared to their sector so far this year.
Brainsway (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why
by Zacks Equity Research
Brainsway (BWAY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Here's Why Brainsway Ltd. Sponsored ADR (BWAY) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does Brainsway Ltd. Sponsored ADR (BWAY) have what it takes to be a top stock pick for momentum investors? Let's find out.
The Zacks Analyst Blog Fulcrum Therapeutics, Heritage Insurance, Latham Group, Seanergy Maritime and BrainsWay
by Zacks Equity Research
Fulcrum Therapeutics, Heritage Insurance, Latham Group, Seanergy Maritime and BrainsWay are included in this Analyst Blog.
5 Best Small-Cap Stocks to Benefit From Interest Rate Cuts
by Nalak Das
We have narrowed our search to five small-cap stocks that have strong momentum. These are FULC, HRTG, SWIM, SHIP and BWAY.
Wall Street Analysts See a 60.85% Upside in Brainsway (BWAY): Can the Stock Really Move This High?
by Zacks Equity Research
The consensus price target hints at a 60.9% upside potential for Brainsway (BWAY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Is Brainsway (BWAY) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Brainsway Ltd. Sponsored ADR (BWAY) and ChromaDex (CDXC) have performed compared to their sector so far this year.
Brainsway Ltd. Sponsored ADR (BWAY) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
Brainsway (BWAY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Why Brainsway (BWAY) Might be Well Poised for a Surge
by Zacks Equity Research
Brainsway (BWAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Wall Street Analysts Think Brainsway (BWAY) Could Surge 72.29%: Read This Before Placing a Bet
by Zacks Equity Research
The mean of analysts' price targets for Brainsway (BWAY) points to a 72.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.